Kaiser Permanente announced a significant AI partnership this week aimed at enhancing value-based care. The West Coast-based health system is deploying Innovaccer’s healthcare AI platform and population health management tools — starting with its Washington market and potentially expanding to new markets in the future.
This initial deployment, which will serve about 650,000 Washington patients, is expected to be complete this summer.
“As we continue to build out our unique set of flexible capabilities, tools, and services — developed by clinicians and experts and grounded in evidence and real-world best practices — we are excited at the prospect of assembling advanced technologies and solutions that can help us accelerate our ability to deliver the best value to our patients and our organization,” Paul Minardi, CEO of the KP Medical Foundation said in a statement.
BioLabs Pegasus Park Cultivates Life Science Ecosystem
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
San Francisco-based Innovaccer was founded in 2014. The healthcare technology company specializes in data-driven solutions that help providers enhance patient care and operation efficiency.
Its healthcare AI platform helps simplify patient care by bringing together data from various disparate sources. By combining all this information, the platform provides a complete and detailed view of each patient’s health, explained Innovaccer CEO Abhinav Shashank.
“This helps doctors, nurses and other healthcare professionals get a clearer understanding of each patient’s situation and deliver better care. Therefore, it is not just a point AI application, but a holistic approach to healthcare AI that helps the healthcare ecosystem journey from data to data-driven decisions,” he remarked.
Innovaccer’s population health product is the other solution that Kaiser is deploying in its Washington market. Similarly to its AI product, Innovaccer’s population health platform also consolidates patient data from various sources, including the EHR, lab results and insurance claims.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
With this comprehensive view, Innovaccer’s platform then applies algorithms to identify potential health risks, predict future medical costs and measure the quality of care delivered.
“For instance, the platform can evaluate a patient’s likelihood of developing chronic conditions such as diabetes or hypertension, allowing healthcare providers to intervene early and mitigate risks. It can also reveal gaps in care, such as missed screenings or follow-up appointments, which can then be addressed promptly,” Shashank said.
The population health product also provides hospitals with real-time reporting and dashboards, which allow healthcare providers to better monitor the health status of all patients under their care, he added.
With Innovaccer’s technology, Kaiser will be able “to avoid spending billions of dollars to replace or modify its EHR and claims systems,” Shashank declared. Instead, the healthcare AI and population health platforms provide a unified data layer that can integrate with Kaiser’s existing infrastructure, allowing for a standardized approach to healthcare delivery across various locations, he noted.
“This unified approach allows Kaiser to scale its world-class clinical processes throughout the country, ensuring consistency in care delivery regardless of location. The unified health record makes it easier for healthcare professionals to track patient history, treatments and outcomes, facilitating better coordination and more informed decision making,” Shashank said.
Photo: elenabs, Getty Images
